TGFB1 and Hepatic fibrosis: Various interventions have been developed, such as TGF-β-neutralizing antibodies, small molecule TGF-β receptor antagonists, small molecule TGF-β signaling inhibitors, and natural compounds, all aiming to block its profibrotic effects, promote reversal of liver fibrosis, and reduce the risk of liver cancer.